Literature DB >> 25819335

Synthesis and structure-activity relationships of boswellic acid derivatives as potent VEGFR-2 inhibitors.

Sida Shen1, Xingyu Xu1, Zhulong Liu1, Junhua Liu2, Lihong Hu3.   

Abstract

A series of AKBA derivatives were synthesized, and evaluated as potent VEGFR-2 inhibitors. The initial biological evaluation indicated that the introduction of C-24 amide group or a heterocycle at C-2,3 position effectively improved the potency. Further structure-activity relationship analysis showed that amide (7, 23, 25, and 26) and heterocycle (19, 34, and 36) substituted AKBA derivatives displayed more potential anti-proliferation activities than AKBA (1) on HUVECs that express high levels of VEGFR-2. Among all tested compounds, compounds 7 and 19 exhibited the best potency (IC₅₀: 2.36 and 2.13 μM) and obvious inhibitory activities with VEGFR-2 inhibition rates of 96% and 94% at 50 μM, respectively.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetyl-11-keto-β-boswellic acid; Structure–activity relationship; Synthesis; VEGFR-2

Mesh:

Substances:

Year:  2015        PMID: 25819335     DOI: 10.1016/j.bmc.2015.03.022

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

Review 1.  Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies.

Authors:  Niege A J C Furtado; Laetitia Pirson; Hélène Edelberg; Lisa M Miranda; Cristina Loira-Pastoriza; Véronique Preat; Yvan Larondelle; Christelle M André
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

2.  Synthesis of 3-O-Acetyl-11-keto-β-boswellic Acid (AKBA)-Derived Amides and Their Mitochondria-Targeted Antitumor Activities.

Authors:  Changhao Li; Qiaobian He; Yuwen Xu; Hongxiang Lou; Peihong Fan
Journal:  ACS Omega       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.